FiercePharma |
Why is Valeant's 'blockbuster' libido drug Addyi a dud? Shoddy marketing, investor lawsuit claims
FiercePharma When Valeant bought Sprout Pharmaceuticals and its controversial female libido drug Addyi, it agreed to a marketing blitz that would bring royalties to Sprout's former shareholders. Valeant bungled the job, those former investors say. And they're ... Valeant Accused of Bungling Marketing of Female Libido Drug Valeant sued for botching marketing of female libido pill |
November 03, 2016 at 09:25AM | marketing - Google News
Why is Valeant's 'blockbuster' libido drug Addyi a dud? Shoddy marketing, investor lawsuit claims - FiercePharma
marketing - Google News
Nenhum comentário:
Postar um comentário